Endometrial Cancer is a type of cancer that begins in the lining of the uterus, most commonly affecting postmenopausal women. Rising prevalence due to increasing obesity rates and aging population, ...

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, ...

ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.

Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Atrial Fibrillation ...

Chandigarh: The PGI is at the forefront of India's efforts to develop indigenous solid tumour cancer drugs, serving as one of the four pivotal Phase 1.

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

Epitopea expands clinical development and research capabilities; forms research & clinical teams as it speeds up to clinical operations: Cambridge, UK Saturday, July 12, 2025, 16: ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the increasing demand for personalized medicines, expansion in clinical research ...

Multifaceted Mechanisms and Future of Diabetic Wound Healing and the rapidly evolving subject area, we are pleased to ...

How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical ...

Verastem Oncology releases primary results from phase 2 RAMP 201 trial of Avutometinib in combo with defactinib: Boston Tuesday, July 15, 2025, 09:00 Hrs [IST] Verastem Oncology, ...